Published in J Invest Dermatol on January 01, 2001
Gangliosides play an important role in the organization of CD82-enriched microdomains. Biochem J (2006) 0.96
Glycosphingolipids and cell death. Glycoconj J (2004) 0.95
The tethering arm of the EGF receptor is required for negative cooperativity and signal transduction. J Biol Chem (2010) 0.93
Ganglioside GM3 depletion reverses impaired wound healing in diabetic mice by activating IGF-1 and insulin receptors. J Invest Dermatol (2013) 0.84
Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it's potential therapeutic implications. Clin Exp Metastasis (2016) 0.75
Ganglioside GM3 Mediates Glucose-Induced Suppression of IGF-1 Receptor-Rac1 Activation to Inhibit Keratinocyte Motility. J Invest Dermatol (2016) 0.75
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell (1992) 16.53
Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol (2000) 15.79
A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells. Nature (1983) 3.56
Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell (1991) 3.49
Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain (1991) 3.07
Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood (1999) 2.22
Control of group C meningococcal disease in Australian aboriginal children by mass rifampicin chemoprophylaxis and vaccination. Lancet (1995) 2.06
Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine. J Infect Dis (1998) 2.00
Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem (1986) 2.00
Diagnostic value of cervical discography in the management of cervical discogenic pain. Conn Med (2000) 1.99
Characterization of Ca2+/calmodulin-dependent protein kinase IV. Role in transcriptional regulation. J Biol Chem (1994) 1.94
Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet (2001) 1.87
Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. Eur J Cancer (2013) 1.85
Oestrogen receptors and prognosis in early breast cancer. Lancet (1979) 1.83
Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J Biol Chem (1984) 1.79
A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas. Oncogene (2006) 1.78
A multiscale retinex for bridging the gap between color images and the human observation of scenes. IEEE Trans Image Process (1997) 1.71
Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland. J Biol Chem (1984) 1.70
Kwashiorkor in the United States: fad diets, perceived and true milk allergy, and nutritional ignorance. Arch Dermatol (2001) 1.66
MaRX: an approach to genetics in mammalian cells. Science (1999) 1.58
Dietary calcium, calcium supplementation, and blood pressure in African American adolescents. Am J Clin Nutr (1998) 1.54
Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer (2011) 1.51
The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. Cell (1992) 1.51
Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiol Scand (2009) 1.50
P blood group regulation of glycosphingolipid levels in human erythrocytes. J Biol Chem (1979) 1.48
Treatment of cutaneous hemangiomas by the flashlamp-pumped pulsed dye laser: prospective analysis. J Pediatr (1992) 1.46
Rapid progression of prostate cancer in men with a BRCA2 mutation. Br J Cancer (2008) 1.45
Partial albinism with immunodeficiency: Griscelli syndrome: report of a case and review of the literature. J Am Acad Dermatol (1998) 1.44
Drug administration to the pregnant or lactating woman: a reference guide for dermatologists. J Am Acad Dermatol (1990) 1.43
Juvenile dermatomyositis presenting with rash alone. Pediatrics (1997) 1.42
Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis. Antimicrob Agents Chemother (1991) 1.39
Response of deep tufted angioma to interferon alfa. J Am Acad Dermatol (1995) 1.39
Methotrexate may lower seizure threshold in patients with epilepsy. J Rheumatol (1992) 1.39
Removal of the entrapped basketed ureteral calculus: a novel technique. J Urol (2000) 1.39
Pseudoporphyria cutanea tarda: two case reports on children receiving peritoneal dialysis and erythropoietin therapy. J Pediatr (1992) 1.38
Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2004) 1.34
Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. Arch Dermatol (1999) 1.34
Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. Oncogene (2011) 1.33
Steroid receptors in early breast cancer: value in prognosis. J Steroid Biochem (1981) 1.31
Loss of receptors for transforming growth factor beta in human T-cell malignancies. Proc Natl Acad Sci U S A (1994) 1.29
The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosis. J Infect Dis (1991) 1.29
Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol (1998) 1.28
Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem (1990) 1.28
Genetic characterization of wild and captive rhesus macaques in China. J Med Primatol (2008) 1.26
Squamous carcinoma of the breast. J Clin Pathol (1978) 1.23
Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation (1994) 1.22
Localized facial flushing in infancy. Auriculotemporal nerve (Frey) syndrome. Arch Dermatol (1997) 1.22
Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation. Br J Cancer (2008) 1.22
Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol (1999) 1.22
Project towards no tobacco use: 1-year behavior outcomes. Am J Public Health (1993) 1.20
ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors. Oncogene (2007) 1.18
Cutaneous changes associated with inflammatory bowel disease. Pediatr Dermatol (1986) 1.16
Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide. J Biol Chem (1995) 1.15
Inhibition of the alternative pathway of human complement by structural analogues of sialic acid. J Immunol (1988) 1.13
A novel KIT mutation results in piebaldism with progressive depigmentation. J Am Acad Dermatol (2001) 1.13
Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer. J Clin Oncol (2001) 1.13
Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide. FEBS Lett (1993) 1.13
Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease. Biol Psychiatry (2001) 1.12
Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587). Clin Cancer Res (1998) 1.12
A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients. Bone Marrow Transplant (2004) 1.12
Development of a Chinese-Indian hybrid (Chindian) rhesus macaque colony at the California National Primate Research Center by introgression. J Med Primatol (2008) 1.12
Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles atherosclerosis study. Circulation (2001) 1.11
Microarray analysis detects novel Pax3 downstream target genes. J Biol Chem (2001) 1.11
Smoking-related diseases: the importance of COPD. Int J Tuberc Lung Dis (2004) 1.10
Rat bite fever in a pet lover. J Am Acad Dermatol (1998) 1.09
Aquagenic palmoplantar keratoderma. J Am Acad Dermatol (2001) 1.09
Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry. Cancer Lett (1999) 1.09
Properties and performance of a center/surround retinex. IEEE Trans Image Process (1997) 1.08
Syphilis partner notification with men who have sex with men: a review and commentary. Sex Transm Dis (2005) 1.07
Treatment options in renal cell carcinoma: past, present and future. Ann Oncol (2007) 1.07
Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism. J Invest Dermatol (1991) 1.06
Animal models: usefulness for studies of fungal pathogenesis and drug efficacy in aspergillosis. Clin Infect Dis (1992) 1.06
Second-gradient models accounting for some effects of microstructure on remodelling of bones reconstructed with bioresorbable materials. Comput Methods Biomech Biomed Engin (2013) 1.05
Acetonitrile-hydrochloric acid hydrolysis of gangliosides for high performance liquid chromatographic analysis of their long chain bases. J Lipid Res (1983) 1.03
Saperconazole therapy in a rabbit model of invasive aspergillosis. Antimicrob Agents Chemother (1992) 1.03
Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppression [correction of suppresion] of activation. Glycobiology (2001) 1.02
Adolescent smoking in Wuhan, China: baseline data from the Wuhan Smoking Prevention Trial. Am J Prev Med (2001) 1.02
Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR. Gene Ther (2004) 1.02
Regulation of B cell function by the immunosuppressive agent leflunomide. Transplantation (1996) 1.02
Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2. Clin Genet (2010) 1.01
Visual loss in pseudotumor cerebri. Incidence and defects related to visual field strategy. Arch Neurol (1987) 1.01
Primary generalized and localized hypertrichosis in children. Arch Dermatol (2001) 1.01
Tumour characteristics among women with very low-risk breast cancer. Breast Cancer Res Treat (2012) 0.99
Full-thickness surgical excision for the treatment of inflammatory linear verrucous epidermal nevus. Ann Plast Surg (2001) 0.99
Evolution of karyotypic abnormalities and C-MYC oncogene amplification in human colonic carcinoma cell lines. Chromosoma (1985) 0.99
Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. Br J Haematol (2000) 0.99
Age-specific incidence rates for breast cancer in carriers of BRCA1 mutations from Norway. Clin Genet (2012) 0.98
A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen. J Invest Dermatol (1985) 0.98
Linkage analysis of X-linked mental retardation with and without fragile-X using factor IX gene probe. Lancet (1984) 0.98
Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer. Gene Ther (2004) 0.98
Childhood rosacea. Pediatr Dermatol (1992) 0.98
Maternal/congenital syphilis in a large tertiary-care urban hospital. Clin Infect Dis (1993) 0.98
Glycosphingolipids in detergent-insoluble substrate attachment matrix (DISAM) prepared from substrate attachment material (SAM). Their possible role in regulating cell adhesion. Exp Cell Res (1984) 0.98
Effect of gangliosides on activation of the alternative pathway of human complement. J Immunol (1988) 0.97
Localization of the alpha 3 (V) chain of type V collagen in human skin. J Invest Dermatol (1987) 0.97
Consequences of seven novel mutations on the expression and structure of keratinocyte transglutaminase. J Biol Chem (1997) 0.96